SCPH
scPharmaceuticals Inc.Company Information
- Company Name
- scPharmaceuticals Inc.
- CIK
- CIK0001604950
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- SCPH: None
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- SCPH
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-08-13
- Last sale
- 2022-10-10
- Shares purchased (TTM)
- 500,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2025-09-30
- Institutional shares owned
- 36,934,356
- Shares outstanding
- 53,719,662
- Ownership
- 68.75%
Earnings Market Reaction
- Filing date
- —
- Price on filing date
- —
- 1-month reaction
- —
- 3-month reaction
- —
Balance Sheet
Values in millions ($)| Line item | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 41 | 58 | 76 | 91 | 39 | 58 | 47 | 35 | 71 | 75 | 71 | 41 | ||||||
| Short Term Investments | - | - | 0 | - | - | - | 29 | 55 | 32 | 41 | 47 | 4 | ||||||
| Restricted Cash Current | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Accounts Receivable Net Current | 19 | 14 | 12 | 9 | 6 | 6 | 4 | 4 | 2 | 3 | - | - | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 79 | 89 | 106 | 123 | 63 | 77 | 93 | 104 | 114 | 127 | 123 | 47 | ||||||
| Inventory Net | 15 | 14 | 14 | 18 | 15 | 10 | 9 | 7 | 6 | 4 | 1 | - | ||||||
| Prepaid Expense Current | 4 | 3 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | ||||||
| Other Assets Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Restricted Cash Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 0 | 0 | 1 | 1 | ||||||
| Assets | 80 | 91 | 108 | 125 | 65 | 78 | 94 | 106 | 114 | 127 | 124 | 48 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 4 | 5 | 4 | 5 | 5 | 3 | 4 | 3 | 1 | 2 | 2 | 1 | ||||||
| Accrued Liabilities Current | 16 | 11 | 11 | 10 | 7 | 9 | 9 | 7 | 5 | 6 | 5 | 5 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 20 | 16 | 15 | 15 | 13 | 12 | 13 | 11 | 7 | 8 | 7 | 17 | ||||||
| Long Term Debt Current | - | - | - | - | - | - | - | - | - | - | - | 10 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Other Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Long Term Debt Noncurrent | 51 | 51 | 51 | 51 | 40 | 39 | 39 | 38 | 38 | 37 | 37 | - | ||||||
| Derivative Liabilities Noncurrent | - | - | 0 | 0 | 2 | 1 | 4 | 6 | 6 | 7 | 8 | - | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Liabilities | 102 | 96 | 94 | 94 | 56 | 54 | 57 | 57 | 51 | 52 | 52 | 17 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 383 | 381 | 380 | 378 | 322 | 320 | 319 | 317 | 315 | 314 | 299 | 248 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -21 | -5 | 13 | 31 | 9 | 25 | 37 | 49 | 63 | 76 | 72 | 31 | ||||||
| Retained Earnings Accumulated Deficit | -404 | -386 | -366 | -348 | -313 | -295 | -281 | -268 | -252 | -238 | -227 | -217 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | - | 0 | - | - | - | -0 | -0 | -0 | 0 | 0 | - | ||||||
| Liabilities And Stockholders Equity | 80 | 91 | 108 | 125 | 65 | 78 | 94 | 106 | 114 | 127 | 124 | 48 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 53 | 50 | 50 | 50 | 36 | 36 | 36 | 36 | 36 | 36 | 34 | 27 | ||||||
| Shares Outstanding | 53 | 50 | 50 | 50 | 36 | 36 | 36 | 36 | 36 | 36 | 34 | 27 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialscPharmaceuticals Inc. (SCPH) — SEC Financial Statements & Analysis
scPharmaceuticals Inc. (SCPH) is a pharmaceutical preparations company, incorporated in DE. scPharmaceuticals Inc. trades on None as: SCPH. scPharmaceuticals Inc. (SCPH)'s most recent SEC filing is a Form 10-Q for the period ended 2025-06-30, filed with the SEC on 2025-08-07. Based on that filing, On profitability, scPharmaceuticals Inc. posts a gross margin of 68.46%, an operating margin of -133.16%, a net margin of -183.55%, a Return on Equity (ROE) of 1520.24%, a Return on Assets (ROA) of -125.89%, and a Return on Invested Capital (ROIC) of -293.77%. Per share, it reports EPS of $-1.71, diluted EPS of $-1.71, free cash flow per share of $-1.23, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 107.79% year-over-year, net income growth of 51.24% year-over-year, and EPS growth of 9.75% year-over-year. On the balance sheet, it maintains a current ratio of 3.85x, a quick ratio of 2.96x, working capital of $58.30M, a debt-to-equity ratio of -4.77x, a debt ratio of 1.27, an interest coverage ratio of -10.87x, free cash flow of $-65.88M (TTM), and net debt of $10.39M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-1.71
- ROE TTM
- 1520.24%
- ROA TTM
- -125.89%
- Debt To Equity
- -4.77x
- Free Cash Flow TTM
- $-65.88M
- Net Revenue TTM Growth 1Y
- 107.79%
Data as of 2025-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is scPharmaceuticals Inc. in?
scPharmaceuticals Inc. (SCPH) operates in the Pharmaceutical Preparations industry.
What exchange does SCPH trade on?
scPharmaceuticals Inc. (SCPH) trades on the None.
Where is scPharmaceuticals Inc. incorporated?
scPharmaceuticals Inc. is incorporated in DE.
When was scPharmaceuticals Inc. (SCPH)'s most recent SEC filing?
scPharmaceuticals Inc. (SCPH)'s most recent SEC filing is a Form 10-Q for the period ended 2025-06-30, filed with the SEC on 2025-08-07.
What is SCPH's EPS (earnings per share)?
scPharmaceuticals Inc. (SCPH)'s trailing twelve month EPS is $-1.71 as of 2025-06-30.
What is SCPH's ROE (return on equity)?
scPharmaceuticals Inc. (SCPH)'s trailing twelve month Return on Equity (ROE) is 1520.24% as of 2025-06-30.
What is SCPH's ROA (return on assets)?
scPharmaceuticals Inc. (SCPH)'s trailing twelve month Return on Assets (ROA) is -125.89% as of 2025-06-30.
What is SCPH's ROIC (return on invested capital)?
scPharmaceuticals Inc. (SCPH)'s trailing twelve month Return on Invested Capital (ROIC) is -293.77% as of 2024-06-30.